CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 335 enrolled
Drug / intervention
living donor liver transplantation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05132192
NCT05132192N/ACompleted
CompareCT.gov

Outcomes of Surgical Strategies for Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis

Elvan Onur Kirimker·observational·Posted Nov 24, 2021·Updated Nov 24, 2021

In Brief

An observational study evaluating living donor liver transplantation and Thrombectomy or interposition graft for Portal Vein Thrombosis and Liver Transplant; Complications. Completed, enrolled 335 participants.

Detailed Summary

Data of demographic, clinical, laboratory and imaging studies of living donor liver transplantation (LDLT) recipients from two transplant centers were collected. Survival and morbidity rates between patients with and without portal vein thrombosis (PVT) were compared. Risk factors of mortality in the setting of PVT were identified. Intraoperative portal flow measurements were compared before and after portal flow restoration.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPortal Vein Thrombosis, Liver Transplant; Complications
Countries--
CollaboratorsAnkara University, Ankara Guven Hospital

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 24, 2021
Enrollment StartJan 1, 2013
Primary CompletionJul 30, 2020
Study CompletionOct 30, 2020
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 4.6 years ago

Interventions

living donor liver transplantationprocedure

Living donor liver transplantation

Thrombectomy or interposition graftprocedure

Portal flow restoration due to PVT in any manner